Liu, F., Wang, B., Wang, Q., Qi, Z., Chen, C., Kong, L., . . . Liu, Q. (2016). Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML). Oncotarget.
Chicago-stil citatLiu, Feiyang, et al. "Discovery and Characterization of a Novel Potent Type II Native and Mutant BCR-ABL Inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)." Oncotarget 2016.
MLA-referensLiu, Feiyang, et al. "Discovery and Characterization of a Novel Potent Type II Native and Mutant BCR-ABL Inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)." Oncotarget 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.